Status:
COMPLETED
A Single-Patient Study Using AGS 006
Lead Sponsor:
Argos Therapeutics
Conditions:
Pancreatic Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Argos Therapeutics, Inc., (Argos) proposes to study AGS-006 in a subject with newly diagnosed resectable pancreatic cancer. The AGS 006 immunotherapeutic may potentially offer a desired additional opt...
Detailed Description
Single-patient, open-label clinical study: * Events during Pre-Treatment Period: 1. Resection of pancreatic cancer, 2. RNA acquisition from tumor specimen, 3. RNA amplification, 4. Infectiou...
Eligibility Criteria
Inclusion
- A male subject 18 years of age or older with newly diagnosed resectable pancreatic cancer who, in the opinion of the investigator, is suitable for participation in the study will be eligible for inclusion if all of the following criteria apply:
- Able to abstain from taking prohibited prescription or prohibited non-prescription drugs.
- Ability to communicate effectively with study personnel; considered reliable, willing, and cooperative in terms of compliance with the Protocol requirements.
- Voluntary informed consent given to participate in the study.
Exclusion
- Any serious medical condition such as cardiopulmonary disease, circulatory compromise, hepatic or renal dysfunction, or other illness considered by the investigator to constitute an unwarranted high risk for investigational treatment.
- Active autoimmune disease including, but not limited to:
- Active, acute, or chronic clinically significant infections including human immunodeficiency virus (HIV) and viral hepatitis.
- Known hypersensitivity to dimethyl sulfoxide (DMSO).
- Body weight less than 30 kg.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00664482
Start Date
May 1 2007
End Date
October 1 2011
Last Update
January 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rockefeller University
New York, New York, United States, 10021